IV Digoxin Loading Protocol
For adults with normal renal function requiring IV digoxin loading, administer a total loading dose of 8-12 mcg/kg ideal body weight, given as half the total dose initially, then one-quarter of the loading dose every 6-8 hours twice. 1
Loading Dose Administration
The FDA-approved protocol specifies:
- Total loading dose: 8-12 mcg/kg (based on ideal body weight, not actual body weight)
- Initial dose: Give 50% of the total loading dose
- Subsequent doses: Give 25% of the total loading dose at 6-8 hour intervals (twice more)
- Administration rate: Infuse over at least 5 minutes to prevent systemic and coronary vasoconstriction 1
For a 70 kg adult with normal renal function, this translates to approximately 560-840 mcg total loading dose (commonly 500-750 mcg in practice).
Critical Dosing Considerations
Use ideal body weight for dosing calculations, not actual body weight, especially in obese or edematous patients 1. Recent evidence demonstrates that doses >12 mcg/kg IBW result in significantly higher rates of serum digoxin concentrations ≥1.2 ng/mL (50.6% vs 30.0%), which are associated with increased mortality 2.
Dilution and Administration
- Can be given undiluted or diluted with at least 4-fold volume of sterile water, 0.9% NaCl, or 5% dextrose
- Less than 4-fold dilution may cause precipitation
- Do not mix with other drugs in the same container or IV line
- Administer over ≥5 minutes, never as bolus 1
When Loading Doses Are NOT Needed
Loading doses are generally not required in stable patients, particularly those in sinus rhythm 3, 4, 5. The ESC guidelines explicitly state that "loading doses of digoxin are generally not required in stable patients with sinus rhythm" 3. In these cases, initiate with maintenance dosing of 0.25 mg daily (or 0.125 mg in elderly/renal impairment).
Target Serum Concentrations
Target serum digoxin concentration of 0.5-0.9 ng/mL (or 0.6-1.2 ng/mL per ESC) 4, 5. Concentrations >1.0-1.2 ng/mL are associated with increased mortality without additional clinical benefit 5, 2, 6. The traditionally accepted range of 0.8-2.0 ng/mL is outdated and potentially harmful.
Maintenance Dosing After Loading
Following the loading dose, initiate maintenance therapy:
- Standard dose: 2.4-3.6 mcg/kg/day IV (typically 0.125-0.25 mg daily for adults)
- Adjust based on renal function, age, lean body weight, and drug interactions 1
Important Contraindications and Precautions
Absolute contraindications:
- Second- or third-degree AV block (without pacemaker)
- Pre-excitation syndromes (WPW with AF/flutter)
- Known digoxin intolerance 3, 7, 3
Use with extreme caution:
- Sick sinus syndrome
- Concurrent AV nodal blocking agents (beta-blockers, calcium channel blockers)
- Hypokalemia or hypomagnesemia (increases toxicity risk)
- Hypothyroidism
- Elderly patients (>70 years) 8, 7, 5
Clinical Context
The 2010 AHA guidelines specify that IV digoxin loading is appropriate for "stable narrow-complex regular tachycardias" and "control of ventricular rate in atrial fibrillation/flutter," noting its slow onset of action makes it less useful for acute arrhythmias 8. The 2016 ACC/AHA/HRS guidelines provide similar dosing: 0.25-0.5 mg IV bolus, with additional 0.25 mg doses up to maximum 1.0 mg over 24 hours 7.
Critical pitfall: The slow onset of action (peak effect in peripheral tissues occurs hours after administration) means digoxin is not ideal for emergent rate control 8, 9. Consider alternative agents (beta-blockers, calcium channel blockers) when immediate rate control is needed.
Monitoring
- Check serum digoxin concentration 6-8 hours after the last loading dose
- Monitor potassium, magnesium, and renal function closely
- Watch for signs of toxicity: bradycardia, AV block, ventricular arrhythmias, GI symptoms (nausea, anorexia), neurological symptoms (confusion, visual disturbances) 3, 4
- Consider dose reduction before electrical cardioversion 1
Note: Digoxin toxicity can occur even at therapeutic serum concentrations, particularly with electrolyte abnormalities or drug interactions 10. Clinical assessment supersedes serum levels in diagnosing toxicity.